Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results
Strong Fourth Quarter Revenues of $43.1 Million Drive Full Year Revenues of $150.2 Million Reaffirms 2017 Revenue Guidance of $170 - $200 Million and Adjusted EPS of $0.20 - $0.35 DUBLIN, Ireland, March 07, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals …